China Biopharmaceutical (01177) announced that on April 16, 2024, the company spent HK$12.7 million...
According to the Zhitong Finance App, China Biopharmaceutical (01177) announced that on April 16, 2024, the company spent HK$12.7 million to repurchase 5 million shares at a repurchase price of HK$2.54 per share.